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Background: In a working population, common mental complaints like depressed mood and chronic fatigue are
highly prevalent and often result in further deterioration of mental health and consequently absence from work. In
a large occupational health setting, we will evaluate the (cost-) effectiveness of a Minimal Psychological Intervention
(MPI), in reducing symptoms of depression and chronic fatigue in a working population. The MPI is also evaluated
regarding its appreciation by worker, nurse, and occupational health physician (process evaluation). The tailor-made
intervention is administered by nurses, who are trained in the principles of cognitive behavioural therapy and
self-management.
Methods/design: The presented WoPaCoM study (Work Participation of Workers with Common Mental complaints)
is a two-armed randomized controlled trial, comparing MPI with usual care. A total number of 124 workers suffering
from (chronic) mental fatigue or mild to moderate depression will be included. A stratified and block randomization
will be applied, stratifying by customer organisation, income, and gender, using a block size of four. It will include a
baseline measurement and subsequently follow up measurements after 4, 6 and 12 months. The primary outcome
measures are symptoms of either fatigue (using the Checklist Individual Strength) and/or depression (using the
Beck Depression Inventory) and secondary outcome measures include sickness absence, self efficacy, costs and
quality of life. Analysis will include both univariate and multivariate techniques and data will be analysed according
to the intention to treat principle.
Discussion: Patient recruitment in an occupational setting proves to be complicated and time consuming. Shift
work for instance proved to be an obstacle for making appointments for consultation with the nurse. Furthermore,
economic developments might have created job insecurity which negatively influenced participation in the study,
with workers being anxious to be detected as having psychological problems. Additionally, long-term follow-up in
a working population is time-consuming and continuously engages occupational health staff and administrative
personnel to control the process of data gathering. However, if the intervention proves to be effective,
occupational medicine will have a manageable option for treatment of workers who are at risk of loss of
productivity or sickness absence.
Trial registration: Nederlands Trialregister NTR3162* Correspondence: ed.aelfers@dsm.com
1Maastricht University, Research school CAPHRI, Social Medicine, P.O. Box
616, 6200 MD Maastricht, The Netherlands
2ARBOdienst DSM, Occupational Health Services, P.O. Box 27, 6160 MB
Geleen, The Netherlands
© 2013 Aelfers et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and











= T2 + 6 months
T3 Follow-up
T3 = T2 + 6 months




= T0 +110 days
T2  Follow-up
T2 = T1 + 6 Months




= immediately after 
ending intervention
T2 Follow-up
= T1 + 6 months
Intervention groupControl group
Figure 1 Flow-chart WoPaCom study.
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Fatigue and psychological distress are fairly common symp-
toms in the working population [1-3]. Approximately 20% of
the working population report symptoms that fit the concept
of prolonged fatigue [4]. There is evidence that fatigue is cor-
related with lost productive work time and related costs
[5,6]. Fatigue is a predictor of sickness absence [6], future dis-
ability pension [7], and even occupational accidents [8].
There is also evidence that workers visiting their GP with
complaints of fatigue often have higher levels of depressive
complaints [9-11]. Problematic is that such mental health
complaints often go unrecognized in practice [4]. By ignoring
these complaints, symptoms may increase and eventually re-
sult in sickness absence and work-related disability [12-14].
From a preventive point of view, it is essential not to wait
until workers are reported ill. It is important to intervene at
an early stage to obviate aggravation of complaints.
In cases of minor depression, drug-related therapy is not
necessarily the first choice [15-17]. A number of evidence-
based psychological interventions, such as cognitive behav-
ioral therapy and self-management strategies, are preferable
for such complaints. Based on these principles, we previously
developed a Minimal Psychological Intervention, which –
in order to decrease the physicians’ work pressure – can
likely be carried out by specially-trained nurses [18-20].
In the DELTA Study (Depression in Elderly with Long-Term
Afflictions), it was found that the MPI provided an additional
professional tool for nurses who cared for the chronically ill
elderly persons with mild to moderate depressive symptoms
[21]. The MPI was found both acceptable and feasible. The
intervention improved quality of life and reduced the depres-
sive symptoms [22,23].
In the current study, we set out to examine whether the
MPI – as delivered by occupational nurses – is equally ef-
fective in a working population aimed at workers’ com-
plaints of both depressive symptoms and fatigue. In this
WoPaCoM study (Work Participation of workers with
Common Mental complaints) we had the following main
research questions:
1. What is the effect of the occupational nurse-delivered
MPI on the mental health status, quality of life, and
labor participation of workers with (symptoms of)
mental fatigue and/or mild to moderate depressive
symptoms, in comparison with care as usual?
2. How do workers, occupational nurses, and
occupational physicians appreciate the intervention?




WoPaCoM is a study conducted in an Occupational
Health Service in the South of The Netherlands thatstarted at the end of 2007. Data gathering was finished
in 2012. The customers of this service have their activ-
ities in the chemical industry. The two main customer
organizations consist of approximately 6,000 workers in
several settings, jobs and positions, varying from white
and blue collar workers to researchers and administra-
tive personnel. The WoPaCoM study is a two-armed
(stratified) randomised controlled trial (with a block size
of 4), evaluating the effectiveness of the MPI, including a
process evaluation, for decreasing symptoms of fatigue
and depression. After the baseline measurement, follow-
up measurements at 4, 6 and 12 months are carried out
(Figure 1). A total number of 124 participants will be
included. The effect of MPI will be compared with care
as usual. The ethics committee of the Maastricht Uni-
versity Medical Center found that the study was not
subject to the Dutch Medical Research Involving Human
Subjects Act (WMO): subjects were not subjected to in-
vasive treatments, the subjects’ privacy was sufficiently
guaranteed, and the setting was one in which regular oc-
cupational care was evaluated.
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The study takes place at an occupational health service
which performs periodical preventive medical check-ups
once every four years. For the current study, two ques-
tionnaires were added in order to screen for symptoms
of chronic fatigue and symptoms of depression.
The CIS-20 (Checklist Individual Strength) is a 20-item
self-administered questionnaire and measures several
aspects of fatigue being subjective feeling of fatigue, con-
centration, motivation, and physical activity [24,25]. The
items are scored on 7-point Likert scales (1 = “Yes, that is
true”, to 7 = “No, that is not true”). Higher scores indicate a
higher degree of fatigue, more concentration problems,
reduced motivation, and less activity. A cut-off point of >76
was used to define fatigue in a working population [26].
The PHQ-9 (Patients Health Questionnaire) consists of
nine questions regarding the prevalence and intensity of
symptoms of depression over the last two weeks. The re-
sponse options are: “Not at all”, ”Several days”, “More than
half the days” and “Nearly every day”. Its brevity and the
fact that it is a self-administered questionnaire make it a
useful tool in screening for depression in primary care. The
PHQ-9 has been validated for both diagnosing depression
and measuring severity [27-29] and even for evaluating
treatment effects [30,31]. All participants who scored
at least two depressive symptoms at least at “more than
half the days” and at least one of these symptoms was
depressed mood or anhedonia, were eligible. Depressed
mood was present with a PHQ score of >4 (mild depres-
sion), but <20 (moderately severe depression) [32].
Workers with heightened scores of either fatigue and/or
depressed mood were invited for an additional diagnostic
interview to confirm their eligibility and to check for ex-
clusion criteria. The Mini International Neuropsychiatric
Interview (MINI) was used to confirm the diagnosis from
the PHQ-9. The interview was administered by a trained
nurse. The MINI is a validated and reliable diagnostic
structured interview covering 17 disorders based on
DSM-IV criteria [33,34]. A visual analogue scale was also
used to determine the negative impact of the complaints
on daily life functioning (ranging from 0 (no impact) to
100 (extreme impact)). A cut-off point of 30 was arbitrar-
ily chosen. Participants were excluded if the MINI indi-
cated a major depression in combination with a PHQ-9
score of 14 or higher, in case of recent (medical) events as
an explanation for fatigue, serious psycho-social problems,
former episodes of depression or bipolar disorder or psy-
chiatric co-morbidity, passive death wish or suicidal
thoughts, and alcohol or drug dependency (Table 1). If
participants met the criteria for fatigue and depressed
mood, exceeded the score of 30 on the impact visual
analogue scale they were asked for informed consent. Ser-
ious psychiatric conditions would have been referred fur-
ther (e.g. to physician), but this did not occur in our study.Randomisation
After having completed the baseline questionnaire, partici-
pants were randomly assigned to either the intervention
or control group to ensure equal numbers in both groups.
Furthermore, the randomisation was stratified to avoid
possible confounding. The strata are the customer
organization (representing different production plants and
organisational structure), income (low, high as defined by
the median income in the organization), and gender (male,
female). The intervention group received the Minimal Psy-
chological Intervention. The control group received care
as usual, being the standard follow-up by the occupational
health physician. Mostly this consists of additional con-
sultation and follow-up advice. The principles underlying
the intervention (cognitive behavioural therapy and self-
management) have been validated in previous research
[35,36] and we therefore think that our findings are not
substantially biased by the Hawthorne effect. All possible
co-interventions were registered in both intervention as
well as control group.
Minimal Psychological Intervention
The intervention was carried out by a trained occupational
nurse. During a period of at most four months, participants
assigned to the study group had a minimum of 1 and a
maximum of 10 consultations with the nurse. All consulta-
tions took place on an individual basis. There were no
group sessions. The number of and time between visits
depended on the participant’s progress and was thus tailor-
made. The Minimal Psychological Intervention contains
elements from the Chronic Disease Self-Management Pro-
gram (CDSMP) by Lorig and Gonzales [37], the Reattribu-
tion model from Goldberg [38] and from the work of the
project group of the Interventie Studie Eerste Lijn
(INSTEL) [39]. The intervention aims at teaching workers
to take responsibility for day-to-day management of their
problems and its consequences for daily functioning.
The MPI consists of five phases: Phase 1: The nurse
explores the participants’ cognitions on the origin of
symptoms and complaints, and their relation to limita-
tions and behaviour. Phase 2: The participant keeps a
diary, where he or she records symptoms, complaints,
thoughts, worries, related feelings, and behaviour. Phase
3: Using information from the diary, the nurse chal-
lenges the participant to link his behavioural strategies
to his or her complaints. Phase 4: Introduction of the
self-management approach by the nurse. The participant
explores his or her possibilities to alter his or her behav-
iour. He or she then makes a plan on how to solve per-
ceived problems and sets specific goals to be reached
before the next consultation with the nurse. Phase 5:
Evaluation of the progress in achieving the goals.
After a participant has completed these five phases suc-
cessfully, he or she is supposed to be able to apply the
Table 1 Inclusion and exclusion criteria as applied by the occupational nurse
Inclusion criteria: Exclusion criteria:
- Score PHQ-9 > 3 < 14 - Severe / major depression
- Score CIS-20 > 76 - Major psychiatric problems ( e.g. bipolar depression, schizophrenia, suicidal risk)
- Burden in daily life > 30 (visual analogue 0–100) - Current psychological/psychiatric treatment
- Relevant clinical disease
- (Drug) Addiction(s)
- Recent (life) events strongly related to fatigue and depression (e.g. recent (major) surgery)
Table 2 List of instruments (questionnaires/variables)
Variable/ used instrument Moment in time





PHQ-9 [27-29] X X
CIS20 [25,26] X X X X X
SF-36 [40] X X X X
BDI [38] X X X X
SCL (Anxiety scale) [40] X X X X
UCL [44] X X X X
Pearlin & Schooler Mastery [41] X X X X
Sherer/Bosker (GSE) [42] X X X X
Prodisq (module C-E) [46,47] X X X X
Chronic disease X X
*PMCU Periodic Medical Check Up.
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or she may encounter in the future. Nurses performing
the diagnostic interview with a particular participant did
not perform the MPI in that particular participant.
The training program for nurses
During four 8h sessions, with 2-week time intervals, and
the last with a four-week-interval, five nurses were trained
by experienced trainers (a behavioural scientist with experi-
ence in cognitive behaviour therapy, a psychiatrist and a
pharmacist) on how to apply both the diagnostics as well as
the intervention. In between training days, nurses practised
their newly learned skills on a pilot patient. At the end of
training, two of the nurses who showed the most affinity
with and best availability for performing the MPI were
selected to participate in the intervention. As mentioned
earlier, the training program has previously shown to be
feasible, attractive and successful among nurses [18-20], but
is evaluated again in the current study. Booster sessions
were held monthly during the first part of the study and
then gradually scaled down depending on the specific needs
of the nurses; both a psychiatrist and a psychologist could
be contacted by telephone to discuss cases at any time.
Data collection
Data are collected at four points in time: at baseline (T0),
one week after the intervention period (T1), and at six
and twelve months after the intervention period (T2, T3)
(Figure 1). The intervention period for participants allo-
cated to the intervention group varies from one week to
four months. T1 (the first follow-up phase) for the control
group was set at 4 months, which was the estimated mean
duration of the intervention period in the intervention
group. Data were collected using self-administered ques-
tionnaires (Figure 1). Workers and nurses allocated to the
intervention group were well aware of the allocated arm.
Randomisation and data collection was carried out by sep-
arate administrative personnel members without any com-
peting interests.
Effect evaluation
Table 2 provides an overview of the outcome measures.
The primary outcome measures in this study are fatigue
as measured with the CIS-20 and the level of depressionas measured with the Beck Depression Inventory (BDI)
[40,41]. Secondary outcome measures in the study are
quality of life as measured with the SF-36 [42], Mastery
using the Personal Mastery Scale developed by Pearlin
and Schooler [43], and General Self Efficacy [44,45].
Sick-leave data were available from official plant registra-
tions. Varying covariates were measured. Information on
demographic factors (age, gender, marital status, religion,
education, occupation, and income) was collected in the
screening phase. Other measures were coping using the
active coping, avoidant coping and passive coping scales
from the Utrecht Coping List (UCL) [46], anxiety
assessed using the anxiety subscale from the Symptom
Checklist (SCL-90) [47], co-morbidity using a 24-item
chronic conditions list (e.g. heart disease, cancer) and
16-item life-events list where patients report which life
events they have experienced in the past year, and how
they value these events (positive, negative, or neutral).
To check for contamination in the control group, two
questions are added in the T3 questionnaire asking
whether or not workers in the control group had heard,
used parts of, or somehow benefited from the MPI.
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For an economic evaluation, several modules of the
PROductivity and DISease Questionnaire (PRODISQ)
were used for the measurement of productivity costs. The
modular questionnaire covers all relevant aspects of the
relationship between health and productivity. In this study
we will concentrate on productivity of individual partici-
pants. We used several PRODISQ modules including ab-
sence from work (module C), compensation mechanisms
that may reduce productivity loss (module D), and
reduced productivity at work (module E) [48,49]. Absence
from work is measured as the total number of lost work-
ing days as well as the number of sick-leave episodes
within a period of three months. Compensation mechan-
isms include the compensation of sick leave days by either
the worker himself or a colleague, with or without extra
productivity cost. Productivity cost being differentiated in
the amount of work and the quality of work.
Analysis
Data will be analysed according to the intention to treat
principle. Despite participants dropping out of the inter-
vention or not returning follow-up questionnaires, each
individual is analysed as randomized (either control or
intervention). We tried to encourage (potential) drop-
outs to return their questionnaires in order to have
complete data as much as possible. But if this was not
possible, available (but not complete) data will still be
included in the multilevel repeated measures analysis;
this type of analysis better allows incomplete data. Fi-
nally, in the forthcoming articles, we will give full insight
into the response rates at all phases of the study and
consideration of the extent to which this might have
caused specific biases.
Changes in primary and secondary outcome measures
between the intervention and the control group will be
analysed using both univariate and multivariate techni-
ques. Models will be adjusted for baseline differences,
age, gender, and socioeconomic status. Potential add-
itional confounding factors and effect modifiers (covari-
ates) will be checked separately and when necessary
included in the model. If numbers permit, subgroup ana-
lyses will study the robustness of the findings across
organizations and workers with a low and high income.
Power calculation
Using an individual randomization scheme, assuming
an α of 0.05, a 1 – β of 0.90, and a decrease in symp-
toms of depression and/or fatigue of 25 percent in the
intervention group versus a 5 percent decrease in the
control group, 62 persons per arm were needed. As we
expected that 25% percent would stop participating
after baseline (attrition), 83 persons per arm had to be
initially recruited [50,51].Process evaluation
The aim of the process evaluation is to assess how the
intervention is perceived e.g. appreciated by all partici-
pants (i.e. workers and nurses). Using the framework of
Jonkers and colleagues [19], it focuses on the following
outcomes. The reach of the intervention, being defined as
the proportion of the intended target population that ac-
tually participated in the intervention. The dose delivered,
defined as the completeness of the intervention and num-
ber and duration of the intervention visits. Dose received,
is described in two concepts, namely exposure and satis-
faction. Exposure is the extent to which participants ac-
tively engage with and are receptive to the intervention,
and satisfaction is defined as participants's satisfaction
with the intervention [52]. Barriers are described as the
extent to which problems were encountered during the
intervention. Data were collected using questionnaires
filled out by nurses after every intervention visit, by means
of checklists that were kept by the nurse for every partici-
pant (regarding which steps of the intervention had been
taken), and by questionnaires filled out by participants
after the end of the intervention.
Discussion
Progress of the study
In 2007, based on the occupational health service’s ex-
perience, it was estimated that it would take approxi-
mately two years to recruit participants. However, both
the participation rates to the medical check-ups and the
return rates of the screening questionnaires were smaller
than expected and decreased substantially, particularly
during the first phase of the economic crisis in Europe
(2009). Increased perceptions of job insecurity might
underlie these trends. Increasing efforts were needed to
keep participants involved in the intervention itself, but
also during the one-year follow-up. We ended inclusion
in the study in April 2011 and the intervention has been
administered to all participants in the intervention arm.
Data collection was completed in June 2012. 127 Partici-
pants have completed their follow-up questionnaires. Of
all participants initially included in the study 93% were
male and 7% female (which was expected given the gen-
der distribution in the plants). As per the stratified and
blocked design, there is an equal number of intervention
and control participants in the different strata.
Future implementation
If this intervention proves to be effective in reducing de-
pression and fatigue and in improving quality of life, im-
plementation of the intervention in the occupational
health care system is considered and anticipated. An im-
plementation and dissemination plan will be developed
that might be of use for dissemination beyond the study
plant. Additional arguments for such dissemination and
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in sick leave data and productivity figures.
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